quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:05:00·2d
PRRelease
Pacific Biosciences of California Inc. logo

PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing

PACB· Pacific Biosciences of California Inc.
Industrials
Original source

Companies

  • PACB
    Pacific Biosciences of California Inc.
    Industrials

Recent analyst ratings

  • Mar 6UpdateBarclays$1.50
  • Nov 11UpdateUBS-
  • Jun 3UpdateJefferies$4.00
  • Apr 22UpdateJP Morgan-
  • Apr 18UpdateGoldman$2.50
  • Dec 14UpdateStephens$11.00

Related

  • SEC7h
    SEC Form DEFA14A filed by Pacific Biosciences of California Inc.
  • SEC7h
    SEC Form DEF 14A filed by Pacific Biosciences of California Inc.
  • PR7d
    PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
  • PR8d
    PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
  • INSIDER13d
    SEC Form 4 filed by Gibson Christopher
  • INSIDER20d
    SEC Form 4 filed by Gibson James R Ii
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Pacific Biosciences of California Inc.
  • PR36d
    Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022